Bright Minds Biosciences Inc (DRUG)

$1.16

+0.07

(+6.42%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $1.10
    $1.31
    $1.16
    downward going graph

    5.02%

    Downside

    Day's Volatility :15.89%

    Upside

    11.45%

    downward going graph
  • $0.93
    $6.44
    $1.16
    downward going graph

    19.83%

    Downside

    52 Weeks Volatility :85.56%

    Upside

    81.99%

    downward going graph

Returns

PeriodBright Minds Biosciences IncIndex (Russel 2000)
3 Months
3.57%
0.0%
6 Months
-39.58%
0.0%
1 Year
-65.58%
0.0%
3 Years
-97.19%
-19.4%

Highlights

Market Capitalization
4.9M
Book Value
$1.27
Earnings Per Share (EPS)
-0.97
Wall Street Target Price
4.87
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-38.38%
Return On Equity TTM
-71.69%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-0.97
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Bright Minds Biosciences Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 319.83%

Current $1.16
Target $4.87

Technicals Summary

Sell

Neutral

Buy

Bright Minds Biosciences Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bright Minds Biosciences Inc
Bright Minds Biosciences Inc
10.48%
-39.58%
-65.58%
-97.19%
-97.19%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bright Minds Biosciences Inc
Bright Minds Biosciences Inc
NA
NA
NA
0.0
-0.72
-0.38
NA
1.27
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bright Minds Biosciences Inc
Bright Minds Biosciences Inc
Buy
$4.9M
-97.19%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Bright Minds Biosciences Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 59.9% return, outperforming this stock by 125.5%

Institutional Holdings

  • AdvisorShares Investments, LLC

    3.94%
  • Royal Bank of Canada

    0.01%

Company Information

Organization
Bright Minds Biosciences Inc
Employees
0
CEO
Mr. Ian McDonald
Industry
Miscellaneous

FAQs